Global Genomics Life Science tools market is expected to grow by 6% a year over the next five years

"The Global Genomics Life Science research tool market is expected to grow by 6% a year over the next five years, while a new generation of sequencing instruments is expected to grow by 16% a year," Decibio, a life science market research firm, said in a report published on April 12, 2012.

In the report, Decibio, based in Los Angeles, estimates that the market for life sciences research tools will grow from $37.4 billion trillion in 2011 to $45.8 billion, with an annual compound growth rate of 4%. Decibio said the 2016 genome market was expected to grow to 8.9 billion dollars in 2011, driven by the continued adoption of a new generation of sequencing instruments.

Decibio's partner, Stéphanebudel, said in an e-mail to genomeweb that genomics "is expected to be the fastest growing segment of the market for life sciences," adding that the new generation sequencing technology "is really changing the game." ”

The market size of the new generation of sequencing instruments was expected to reach $2.25 billion in 2016, and in 2011 the figure was $1.05 billion, and the growth driver was mainly due to lower cost of reagents and instruments. In the report, the technology has surpassed expectations over the past five years, and the entire genome sequencing price has fallen from $3 billion trillion 10 years ago to today's $3000 trillion.

According to Decibio's report, looking to the future, the sequencing of human genomes for genetic variation, as well as repeated sequencing and expression analysis of cancer biopsies, will continue to drive the technology to be used. At the same time, the development of new applications-such as methylation and miRNA from scratch-and more affordable development platforms, such as Iontorrent's PGM instruments and Ionproton, and Illumina Miseq, will be key to growth drivers.

However, the good news for the next generation of sequencing may mean that chips and capillary electrophoresis sequencing technology will fall into "trouble", both of which will need to find suitable applications and customers, Budel said. In the next five years, the chip market annual composite growth rate is expected to decline to 1%, to 2016 the size of the chip market is expected to be 1.3 billion U.S. dollars, and chip market in gene expression of the sharp drop can be made up by the CGH/SNP chip market. The annual compound growth rate of capillary electrophoresis was reduced to 2%, and the market was expected to be 600 million U.S. dollars by 2016.

Another High-growth technology area is the digital Pcr,decibio estimate that the technology's composite growth rate will soar to 90%, from 2011 10 million to $250 million in 2016. Budel says the technology is "finally getting back to the market from the big suppliers", such as Lifetechnologies and Bio-rad.

Last fall, bio-rad1.62 billion dollars to buy quantalife and into the digital PCR market.

Among other techniques in genomics, Decibio said that from 2011 to 2016 the QPCR market will have a 6% annual compound growth rate, the market scale climbed to 2.95 billion U.S. dollars, and the PCR market compound growth rate of only 1%, the market size of 950 million U.S. dollars.

In addition, the Desibio is expected to have a composite growth rate of 4% in the proteomics market, which is expected to be 3.9 billion U.S. dollars by 2016.

The report also said that the growth of the Global Life science research tool market would be "ignited" by the market demand in Brazil, Russia, India and China, which is expected to have a composite growth rate of 13% per cent in the four countries.

While the United States and Europe will be challenged by shrinking government funding,

But the market for life science research tools in Brazil and China is expected to grow at least 15% a year, while India's growth rate should be between 10% and 15%, and the Russian market growth rate is expected to be between 5% and 10%, Decibio said.

The driving force for market growth will also come from the application market, which, according to Decibio, will increase by 12% over the next five years. Decibio added that the High-growth application markets include ag-bio, food pathogens, environmental and water quality testing.

According to Decibio's report, companies that have made good use of high-growth market opportunities are becoming larger companies through diversified portfolios, such as Lifetechnologies, Thermo Fisher Technology, Bectondickinson, and Sigma-aldrich.